These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10890154)

  • 1. Synthetic conversion of ACAT inhibitor to acetylcholinesterase inhibitor.
    Obata R; Sunazuka T; Otoguro K; Tomoda H; Harigaya Y; Omura S
    Bioorg Med Chem Lett; 2000 Jun; 10(12):1315-6. PubMed ID: 10890154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification and structure-activity relationships of pyripyropenes. 3. Synthetic conversion of pyridine-pyrone moiety.
    Obata R; Sunazuka T; Tian Z; Tomoda H; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1997 Mar; 50(3):229-36. PubMed ID: 9127194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
    Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of acyl CoA:cholesterol acyltransferase.
    Vaccaro W; Amore C; Berger J; Burrier R; Clader J; Davis H; Domalski M; Fevig T; Salisbury B; Sher R
    J Med Chem; 1996 Apr; 39(8):1704-19. PubMed ID: 8648610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.
    Azuma Y; Kawasaki T; Ikemoto K; Obata K; Ohno K; Sajiki N; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1998 Nov; 78(3):355-64. PubMed ID: 9869270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
    Ohshiro T; Rudel LL; Omura S; Tomoda H
    J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyl-CoA : cholesterol acyltransferase inhibitors from Magnolia obovata.
    Kwon BM; Kim MK; Lee SH; Kim JA; Lee IR; Kim YK; Bok SH
    Planta Med; 1997 Dec; 63(6):550-1. PubMed ID: 9434609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoform-specific inhibitors of ACATs: recent advances and promising developments.
    Ohshiro T; Tomoda H
    Future Med Chem; 2011 Dec; 3(16):2039-61. PubMed ID: 22098352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AS-183, a novel inhibitor of acyl-CoA: cholesterol acyltransferase produced by Scedosporium sp. SPC-15549.
    Kuroda K; Yoshida M; Uosaki Y; Ando K; Kawamoto I; Oishi E; Onuma H; Yamada K; Matsuda Y
    J Antibiot (Tokyo); 1993 Aug; 46(8):1196-202. PubMed ID: 8407580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
    Astles PC; Ashton MJ; Bridge AW; Harris NV; Hart TW; Parrott DP; Porter B; Riddell D; Smith C; Williams RJ
    J Med Chem; 1996 Mar; 39(7):1423-32. PubMed ID: 8691472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and pharmacology of aortic-selective acyl-CoA: Cholesterol O-acyltransferase (ACAT/SOAT) inhibitors.
    Shibuya K; Kawamine K; Miura T; Ozaki C; Edano T; Mizuno K; Yoshinaka Y; Tsunenari Y
    Bioorg Med Chem; 2018 Aug; 26(14):4001-4013. PubMed ID: 29945757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human acyl-CoA: cholesterol acyltransferase inhibitory activities of aliphatic acid amides from Zanthoxylum piperitum DC.
    Park YD; Lee WS; An S; Jeong TS
    Biol Pharm Bull; 2007 Jan; 30(1):205-7. PubMed ID: 17202689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillium griseofulvum F1959, high-production strain of pyripyropene a, specific inhibitor of acyl-CoA: cholesterol acyltransferase 2.
    Choi JH; Rho MC; Lee SW; Choi JN; Lee HJ; Bae KS; Kim K; Kim YK
    J Microbiol Biotechnol; 2008 Oct; 18(10):1663-5. PubMed ID: 18955816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
    Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyripyropenes, novel ACAT inhibitors produced by Aspergillus fumigatus. IV. Structure elucidation of pyripyropenes M to R.
    Tomoda H; Tabata N; Yang DJ; Namatame I; Tanaka H; Omura S; Kaneko T
    J Antibiot (Tokyo); 1996 Mar; 49(3):292-8. PubMed ID: 8626247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of membrane environment on inhibition of acyl-CoA:cholesterol acyltransferase by a range of synthetic inhibitors.
    Harte RA; Yeaman SJ; Jackson B; Suckling KE
    Biochim Biophys Acta; 1995 Oct; 1258(3):241-50. PubMed ID: 7548193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical modification and structure-activity relationships of pyripyropenes. 2. 1,11-Cyclic analogs.
    Obata R; Sunazuka T; Kato Y; Tomoda H; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1996 Nov; 49(11):1149-56. PubMed ID: 8982344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of F-1394, an acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on ACAT activity in HepG2 cells and on hepatic secretion of lipids in Triton WR-1339-induced hyperlipidemic rats: possible role of hepatic ACAT in very low density lipoprotein secretion.
    Aragane K; Kusunoki J; Kitamine T; Yamaura T; Ohnishi H
    Jpn J Pharmacol; 1998 Mar; 76(3):309-12. PubMed ID: 9593225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification and structure-activity relationships of pyripyropenes. 1. Modification at the four hydroxyl groups.
    Obata R; Sunazuka T; Li Z; Tian Z; Harigaya Y; Tabata N; Tomoda H; Omura S
    J Antibiot (Tokyo); 1996 Nov; 49(11):1133-48. PubMed ID: 8982343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of acyl-CoA: cholesterol acyltransferase. II. Preparation and hypocholesterolemic activity of optically active dibenz[b,e]oxepin-11-carboxanilides.
    Kumazawa T; Yanase M; Shirakura S; Ohishi E; Yamada K; Matsumiya S; Kono M
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):222-5. PubMed ID: 8582041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.